Disseminated Talaromyces marneffei And Mycobacterium avium Infection Accompanied Sweet’s Syndrome In A Patient With Anti-Interferon-γ Autoantibodies: A Case Report

References

• Sexton P, Harrison AC. Susceptibility to nontuberculous mycobacterial lung disease. Eur Respir J. 2008;31(6):1322–1333. doi:10.1183/09031936.0014000718515557
   PubMed Web of Science ®Google Scholar
• Nekooie-Marnany N, Deswarte C, Ostadi V, et al. Impaired IL-12- and IL-23-mediated immunity due to IL-12Rbeta1 deficiency in Iranian patients with mendelian susceptibility to mycobacterial disease. J Clin Immunol. 2018;38(7):787–793. doi:10.1007/s10875-018-0548-130255293
   PubMed Web of Science ®Google Scholar
• Browne SK, Holland SM. Anticytokine autoantibodies in infectious diseases: pathogenesis and mechanisms. Lancet Infect Dis. 2010;10(12):875–885. doi:10.1016/S1473-3099(10)70196-121109174
   PubMed Web of Science ®Google Scholar
• Tang BS, Chan JF, Chen M, et al. Disseminated penicilliosis, recurrent bacteremic nontyphoidal salmonellosis, and burkholderiosis associated with acquired immunodeficiency due to autoantibody against gamma interferon. Clin Vaccine Immunol. 2010;17(7):1132–1138. doi:10.1128/CVI.00053-1020445006
   PubMedGoogle Scholar
• Lee WI, Huang JL, Wu TS, et al. Patients with inhibitory and neutralizing auto-antibodies to interferon-gamma resemble the sporadic adult-onset phenotype of Mendelian Susceptibility to Mycobacterial Disease (MSMD) lacking Bacille Calmette-Guerin (BCG)-induced diseases. Immunobiology. 2013;218(5):762–771. doi:10.1016/j.imbio.2012.08.28123083630
   PubMed Web of Science ®Google Scholar
• Browne SK, Burbelo PD, Chetchotisakd P, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med. 2012;367(8):725–734. doi:10.1056/NEJMoa111116022913682
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Hori T, Ito K, Fujita T, Ishikawa T, Uchiyama T. Disseminated Mycobacterium avium complex infection in a patient with autoantibody to interferon-gamma. Intern Med. 2007;46(13):1005–1009. doi:10.2169/internalmedicine.46.645217603241
   PubMed Web of Science ®Google Scholar
• Koya T, Tsubata C, Kagamu H, et al. Anti-interferon-gamma autoantibody in a patient with disseminated Mycobacterium avium complex. J Infect Chemother. 2009;15(2):118–122. doi:10.1007/s10156-008-0662-819396523
   PubMed Web of Science ®Google Scholar
• Patel SY, Ding L, Brown MR, et al. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol. 2005;175(7):4769–4776. doi:10.4049/jimmunol.175.7.476916177125
   PubMed Web of Science ®Google Scholar
• O’Connell E, Rosen LB, LaRue RW, et al. The first US domestic report of disseminated Mycobacterium avium complex and anti-interferon-gamma autoantibodies. J Clin Immunol. 2014;34(8):928–932. doi:10.1007/s10875-014-0073-925149293
   PubMed Web of Science ®Google Scholar
• Hoflich C, Sabat R, Rosseau S, et al. Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood. 2004;103(2):673–675. doi:10.1182/blood-2003-04-106512947000
   PubMed Web of Science ®Google Scholar
• Doffinger R, Helbert MR, Barcenas-Morales G, et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis. 2004;38(1):e10–e14. doi:10.1086/38045314679469
   PubMed Web of Science ®Google Scholar
• Chan JF, Yee KS, Tang BS, Cheng VC, Hung IF, Yuen KY. Adult-onset immunodeficiency due to anti-interferon-gamma autoantibody in mainland Chinese. Chin Med J (Engl). 2014;127(6):1189–1190.24622460
   PubMed Web of Science ®Google Scholar
• Ku CL, Lin CH, Chang SW, et al. Anti-IFN-gamma autoantibodies are strongly associated with HLA-DR*15:02/16:02 and HLA-DQ*05:01/05:02 across Southeast Asia. J Allergy Clin Immunol. 2016;137(3):945–948 e948. doi:10.1016/j.jaci.2015.09.01826522403
   PubMed Web of Science ®Google Scholar
• Chitasombat M, Supparatpinyo K. Penicillium marneffei Infection in Immunocompromised Host. Curr Fungal Infect Rep. 2012;7(1):44–50. doi:10.1007/s12281-012-0119-5
   Google Scholar
• Chan JF, Lau SK, Yuen KY, Woo PC. Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients. Emerg Microbes Infect. 2016;5:e19. doi:10.1038/emi.2016.1826956447
   PubMed Web of Science ®Google Scholar
• Yu X, Liu P, Liu G, et al. The prevalence of non-tuberculous mycobacterial infections in mainland China: systematic review and meta-analysis. J Infect. 2016;73(6):558–567. doi:10.1016/j.jinf.2016.08.02027717784
   PubMed Web of Science ®Google Scholar
• Aoki A, Sakagami T, Yoshizawa K, et al. Clinical significance of interferon-gamma neutralizing autoantibodies against disseminated nontuberculous mycobacterial disease. Clin Infect Dis. 2018;66(8):1239–1245. doi:10.1093/cid/cix99629126235
   PubMed Web of Science ®Google Scholar
• Chi CY, Lin CH, Ho MW, et al. Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon- autoantibodies and disseminated nontuberculous mycobacterial infections. Medicine. 2016;95:25. doi:10.1097/MD.0000000000003927
   Web of Science ®Google Scholar
• Chetchotisakd P, Kiertiburanakul S, Mootsikapun P, Assanasen S, Chaiwarith R, Anunnatsiri S. Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. Clin Infect Dis. 2007;45(4):421–427. doi:10.1086/52003017638188
   PubMed Web of Science ®Google Scholar
• Phoompoung P, Ankasekwinai N, Pithukpakorn M, et al. Factors associated with acquired anti IFN-gamma autoantibody in patients with nontuberculous mycobacterial infection. PLoS One. 2017;12:4. doi:10.1371/journal.pone.0176342
   Web of Science ®Google Scholar
• Jutivorakool K, Sittiwattanawong P, Kantikosum K, et al. Skin manifestations in patients with adult-onset immunodeficiency due to anti-interferon-gamma autoantibody: a relationship with systemic infections. Acta Derm Venereol. 2018;98(8):742–747. doi:10.2340/00015555-295929701234
   PubMed Web of Science ®Google Scholar
• Xu X, Lao X, Zhang C, et al. Chronic Mycobacterium avium skin and soft tissue infection complicated with scalp osteomyelitis possibly secondary to anti-interferon-gamma autoantibody formation. BMC Infect Dis. 2019;19(1):203. doi:10.1186/s12879-019-3771-330819109
   PubMed Web of Science ®Google Scholar
• Chi CY, Chu CC, Liu JP, et al. Anti-IFN-gamma autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection. Blood. 2013;121(8):1357–1366. doi:10.1182/blood-2012-08-45248223243276
   PubMed Web of Science ®Google Scholar
• Cohen PR, Kurzrock R. Sweet’s syndrome revisited: a review of disease concepts. Int J Dermatol. 2003;42(10):761–778. doi:10.1046/j.1365-4362.2003.01891.x14521689
   PubMed Web of Science ®Google Scholar
• Baerlecken N, Jacobs R, Stoll M, Schmidt RE, Witte T. Recurrent, multifocal Mycobacterium avium-intercellulare infection in a patient with interferon-gamma autoantibody. Clin Infect Dis. 2009;49(7):e76–e78. doi:10.1086/60558119725781
   PubMed Web of Science ®Google Scholar
• Chetchotisakd P, Anunnatsiri S, Nanagara R, Nithichanon A, Lertmemongkolchai G. Intravenous cyclophosphamide therapy for anti-IFN-gamma autoantibody-associated mycobacterium abscessus infection. J Immunol Res. 2018;2018:6473629. doi:10.1155/2018/647362930687765
   PubMed Web of Science ®Google Scholar
• Pruetpongpun N, Khawcharoenporn T, Damronglerd P, et al. Disseminated talaromyces marneffei and mycobacterium abscessus in a patient with anti-interferon-gamma autoantibodies. Open Forum Infect Di. 2016;3:2.
   Web of Science ®Google Scholar